Obstetric Complications: Hypertensive Disorders, APH, PPH & Ectopic Pregnancy

Obstetric emergencies represent acute, life-threatening pathologies that carry high maternal and perinatal morbidity and mortality. Rapid diagnostic triage, prompt pharmacological resuscitation, strict adherence to evidence-based protocols, and multidisciplinary coordination are required to preserve maternal and fetal life.

---

1. Hypertensive Disorders in Pregnancy

Hypertensive disorders complicate roughly 8% to 10% of all pregnancies globally, representing one of the foremost components of the lethal maternal mortality triad (alongside hemorrhage and sepsis).

Diagnostic Spectrum

• Gestational Hypertension: Systolic blood pressure $\ge 140\text{ mmHg}$ and/or diastolic blood pressure $\ge 90\text{ mmHg}$ measured on two occasions at least 4 hours apart, developing after 20 weeks of gestation in a previously normotensive woman, without significant proteinuria or maternal organ dysfunction. Blood pressure typically normalizes within 12 weeks postpartum.
• Preeclampsia: Multisystem endothelial vasospastic disorder defined as new-onset hypertension ($\ge 140/90\text{ mmHg}$) developing after 20 weeks of gestation accompanied by proteinuria ($\ge 300\text{ mg}$ in a 24-hour urine collection, a protein-to-creatinine ratio $\ge 0.3\text{ mg/mg}$, or persistent $\ge 1+$ on urine dipstick). In the absence of proteinuria, preeclampsia is diagnosed if new-onset hypertension occurs with any of the following features of systemic end-organ dysfunction:
  • Thrombocytopenia: Platelet count $< 100{,}000/\mu\text{L}$.
  • Renal Insufficiency: Serum creatinine $> 1.1\text{ mg/dL}$ or doubling of baseline in the absence of renal disease.
  • Impaired Liver Function: Serum transaminases (AST, ALT) elevated to $> 2$ times the upper limit of normal, or severe persistent right upper quadrant/epigastric pain.
  • Pulmonary Edema: Acute respiratory compromise, crackles, tachypnea, desaturation.
  • New-Onset Neurological Disturbances: Unremitting throbbing frontal headache unresponsive to analgesics, scotomata (visual flashes, blurred vision, temporary blindness).
• Severe Preeclampsia Criteria: Blood pressure $\ge 160\text{ mmHg}$ systolic and/or $\ge 110\text{ mmHg}$ diastolic on two occasions at least 4 hours apart while the patient is on bed rest, accompanied by persistent epigastric/RUQ pain (caused by hepatic ischemia and Glisson's capsule distension), intractable headache, visual scotomata, pulmonary edema, or severe thrombocytopenia.
• Eclampsia: The occurrence of new-onset generalized tonic-clonic convulsions and/or unexplained coma in a patient with preeclampsia, occurring antepartum (50%), intrapartum (25%), or postpartum (25%), not attributable to underlying neurological disorders.
• HELLP Syndrome: A severe variant of preeclampsia marked by microangiopathic hemolytic anemia and multiorgan vasospasm:
  • H (Hemolysis): Microangiopathic hemolytic anemia with schistocytes (burr cells) on peripheral blood smear, elevated indirect bilirubin ($\ge 1.2\text{ mg/dL}$), and serum lactate dehydrogenase (LDH $> 600\text{ IU/L}$).
  • EL (Elevated Liver Enzymes): Serum AST or ALT elevated to $\ge 70\text{ IU/L}$.
  • LP (Low Platelets): Platelet count falling below $< 100{,}000/\mu\text{L}$.

Pharmacotherapy for Acute Severe Hypertension

• Therapeutic Goal: To lower blood pressure to safe levels (systolic 140–150 mmHg, diastolic 90–100 mmHg) to prevent maternal hemorrhagic stroke and placental abruption without causing sudden hypoperfusion of the intervillous space.
• First-Line Antihypertensives:
  1. Intravenous Labetalol: Combined alpha- and beta-blocker. Administer 20 mg IV bolus over 2 minutes; if blood pressure remains above threshold after 10–20 minutes, administer 40 mg, then 80 mg every 20 minutes (maximum cumulative dose: 300 mg). Contraindications: Asthma, congestive heart failure, severe bradycardia.
  2. Oral Nifedipine (Immediate-Release): Dihydropyridine calcium channel blocker. Administer 10 to 20 mg orally (swallowed with water, never administered sublingually due to risks of precipitous hypotension); repeat in 20 to 30 minutes if needed.
  3. Intravenous Hydralazine: Peripheral vasodilator. Administer 5 to 10 mg IV bolus over 2 minutes; repeat 5 to 10 mg every 20 minutes as needed (maximum cumulative dose: 20 to 30 mg).
• Absolute Contraindication: ACE inhibitors (e.g., enalapril) and Angiotensin Receptor Blockers (ARBs) are strictly teratogenic throughout pregnancy, causing fetal renal dysgenesis, oligohydramnios, skull hypoplasia, and intrauterine demise.

Anticonvulsant Protocol: Magnesium Sulfate ($MgSO_4$)

Magnesium sulfate is the definitive, globally recognized drug of choice for the prevention and treatment of eclamptic convulsions (vastly superior to phenytoin, diazepam, or lytic cocktails). It acts by blocking peripheral neuromuscular transmission via acetylcholine inhibition, antagonizing NMDA receptors in the CNS, and promoting cerebral vasodilation.

Dosing Protocols

• Pritchard Regimen (Intramuscular Protocol):
  • Loading Dose: 4 g IV (as a 20% solution over 10 to 15 minutes) PLUS 10 g deep IM (5 g of a 50% solution injected into the upper outer quadrant of each buttock, mixed with 1 mL of 2% lidocaine to minimize injection pain).
  • Maintenance Dose: 5 g deep IM (50% solution) every 4 hours into alternating buttocks, continued for 24 hours following delivery or 24 hours after the last convulsion (whichever occurs later).
• Zuspan Regimen (Intravenous Protocol):
  • Loading Dose: 4 g IV (20% solution over 10 to 15 minutes).
  • Maintenance Dose: 1 to 2 g/hour continuous IV infusion administered via an automated volumetric infusion pump for 24 hours postpartum or post-last convulsion.

Mandatory Clinical Toxicity Monitoring

Because magnesium sulfate is excreted almost exclusively by the kidneys, maternal oliguria causes rapid, lethal systemic accumulation. The nurse must verify that the following three clinical parameters are satisfied prior to administering each maintenance dose:

1. Patellar (Knee-Jerk) Reflex: Must be present and intact. (Loss of deep tendon reflexes is the earliest clinical sign of hypermagnesemia, occurring at serum levels of 8 to 10 mEq/L [4 to 5 mmol/L]).
2. Respiratory Rate: Must be $\ge 16\text{ breaths/minute}$. (Respiratory depression occurs at serum levels of 12 mEq/L; respiratory arrest occurs at $> 15\text{ mEq/L}$).
3. Urine Output: Must be at least $\ge 30\text{ mL/hour}$ (or $\ge 100\text{ mL}$ over the preceding 4 hours) via an indwelling Foley catheter.

Specific Antidote for Magnesium Toxicity: If patellar reflexes disappear, respiratory rate falls below 16/min, or respiratory depression occurs, immediately halt the magnesium sulfate infusion and administer Calcium Gluconate 10% solution: 10 mL (1 g) by slow intravenous push over 10 minutes.

Nursing Management of Eclamptic Seizures

• Call aloud for emergency assistance and summon the obstetric rapid response team.
• Protect the woman from physical trauma; turn her into the left lateral recovery position to optimize uteroplacental blood flow and prevent aspiration of oral secretions.
• Maintain airway patency; do not attempt to force tongue blades or objects between clenched teeth; suction oral secretions gently after the convulsion ceases.
• Administer high-flow oxygen at 10 L/min via a non-rebreather face mask.
• Secure patent intravenous access and administer the magnesium sulfate loading dose.
• Assess maternal vitals, monitor FHR for post-ictal bradycardia, evaluate cervical dilation, and prepare for delivery once maternal hemodynamic stabilization is achieved.

---

2. Antepartum Hemorrhage (APH)

Antepartum hemorrhage is defined as bleeding from or into the genital tract occurring from 20 to 28 weeks of gestation until the delivery of the baby. The two paramount obstetric etiologies are Placenta Previa and Abruptio Placentae.

Placenta Previa vs. Abruptio Placentae

---

3. Postpartum Hemorrhage (PPH)

Postpartum hemorrhage is the single leading cause of maternal mortality worldwide. Traditionally defined as blood loss $> 500\text{ mL}$ following a vaginal delivery or $> 1{,}000\text{ mL}$ following a cesarean delivery, contemporary clinical guidelines define PPH as any cumulative blood loss $\ge 1{,}000\text{ mL}$ or blood loss accompanied by signs and symptoms of hypovolemia (tachycardia, hypotension, pallor, oliguria) within 24 hours of birth. The 2025 WHO/FIGO/ICM PPH recommendations lower the diagnostic threshold to about 300 mL of objectively measured blood loss (calibrated drape) when vital signs are abnormal, and launch the MOTIVE bundle at diagnosis: uterine Massage, Oxytocics, Tranexamic acid, IV fluids, Vaginal/genital-tract examination, and Escalation.

Classification & Etiology: The "4 Ts" Framework

• Primary PPH: Occurs within the first 24 hours following delivery (uterine atony accounts for 70% to 80% of cases).
• Secondary PPH: Occurs after 24 hours and within the puerperium (6 weeks; some guidelines extend this to 12 weeks), predominantly caused by retained placental cotyledons, subinvolution of the placental site, or puerperal endometritis.

Step-by-Step Emergency Management of Atonic PPH

1. Summon Immediate Assistance: Activate the obstetric hemorrhage rapid response protocol; alert senior obstetrician, anesthesia team, and blood bank.
2. Fundal Massage & Bimanual Compression: Immediately perform vigorous abdominal fundal massage. If bleeding persists, execute bimanual uterine compression: insert a gloved right hand into the anterior vaginal fornix, forming a fist against the anterior uterine wall, while the left external hand compresses the posterior uterine wall over the abdomen, pressing the two walls firmly together.
3. Decompress the Bladder: Insert an indwelling Foley catheter. A distended bladder mechanically pushes the uterus upward and to the right, inhibiting myometrial contraction. Catheterization also provides essential hourly urine output monitoring.
4. Resuscitation: Administer 100% oxygen via non-rebreather mask; establish two large-bore (14- or 16-gauge) peripheral IV lines; draw blood for emergent crossmatch (4–6 units PRBCs), CBC, and coagulation panel; initiate rapid infusion of warmed balanced crystalloids (lactated Ringer's).
5. Pharmacological Uterotonics:
   • Oxytocin: First-line agent. Infuse 20 to 40 IU diluted in 1,000 mL normal saline at a rate of 250 to 500 mL/hour. (Never administer undiluted IV bolus, as it causes precipitous systemic vasodilation, hypotension, and fatal arrhythmias).
   • Methylergonovine (Methergine): Ergot alkaloid producing sustained tetanic myometrial contraction. Administer 0.2 mg IM or intramyometrially. Absolute Contraindication: Maternal hypertension, preeclampsia, or cardiovascular disease, as it induces intense vasoconstriction and cerebrovascular hypertensive crises.
   • Carboprost Tromethamine (15-methyl $PGF_{2\alpha}$ / Hemabate): Prostaglandin F2-alpha analogue. Administer 250 mcg deep IM or intramyometrially every 15 to 90 minutes (maximum: 8 doses / 2 mg). Absolute Contraindication: Active bronchial asthma, as it triggers profound bronchospasm and pulmonary vasoconstriction. Frequent side effects include profuse diarrhea, vomiting, and pyrexia.
   • Misoprostol (Prostaglandin E1): Administer 800 to 1,000 mcg per rectum (or 800 mcg sublingually/buccally). Stable at room temperature, making it a critical agent in low-resource environments.
   • Tranexamic Acid (TXA): Antifibrinolytic (not a uterotonic). Give 1 g IV over 10 minutes within 3 hours of birth for any PPH, with a second 1 g dose if bleeding continues after 30 minutes or restarts within 24 hours (WHO).
6. Tamponade & Surgical Interventions (Refractory PPH):
   • Intrauterine Balloon Tamponade: Insert a Bakri balloon (instilled with 300 to 500 mL sterile saline) or condom catheter to exert internal hydrostatic compression against bleeding uterine sinusoids.
   • Surgical Laparotomy: Compression sutures (B-Lynch brace suture); bilateral uterine artery ligation; internal iliac (hypogastric) artery ligation.
   • Peripartum Hysterectomy: The definitive, life-saving intervention executed when medical and compressive measures fail to control hemorrhage.

---

4. Ectopic Pregnancy

An ectopic pregnancy occurs when a fertilized blastocyst implants outside the endometrial cavity of the uterus. Implantation occurs within the fallopian tube in $> 95\%$ of cases, with the ampulla being the most common anatomical site (~80%), followed by the isthmus (~12%), fimbria (~5%), and interstitial/cornual segment (~2%).

Clinical Presentation

• Unruptured Ectopic: The classic clinical triad consists of:
  1. Amenorrhea (typically 6 to 8 weeks following LMP).
  2. Unilateral lower abdominal / pelvic pain (dull, aching discomfort).
  3. Abnormal vaginal bleeding / spotting (scanty, dark brown "prune juice" discharge).
• Ruptured Ectopic (Life-Threatening Emergency):
  • Sudden onset of excruciating, sharp, stabbing unilateral pelvic pain radiating across the lower abdomen.
  • Referred Shoulder Tip Pain (Kehr's Sign): Intraperitoneal blood pools in the subdiaphragmatic space, irritating the diaphragmatic peritoneum innervated by the phrenic nerve (roots C3, C4, C5), causing referred pain to the supraclavicular shoulder tip.
  • Severe peritoneal irritation: involuntary guarding, rebound tenderness, and extreme cervical motion tenderness (chandelier sign on pelvic exam).
  • Cullen's Sign: Faint, bluish periumbilical ecchymosis indicating massive hemoperitoneum.
  • Signs of acute hypovolemic shock: profound pallor, diaphoresis, hypotension, tachycardia, syncopal collapse.

Diagnostic & Therapeutic Management

• Transvaginal Ultrasound (TVS): Demonstrates an empty uterine cavity with an adnexal mass containing a gestational sac, frequently accompanied by free fluid in the pouch of Douglas.
• Quantitative Serum $\beta$-hCG: Evaluated relative to the discriminative zone ($\beta\text{-hCG} \ge 1{,}500–2{,}000\text{ mIU/mL}$). An empty intrauterine cavity on TVS in the presence of $\beta$-hCG above this threshold confirms ectopic pregnancy. Normal intrauterine pregnancies show doubling of $\beta$-hCG every 48 hours; ectopic gestations demonstrate subnormal rises ($< 35\%$) or plateaus.
• Medical Management (Methotrexate): A folic acid antagonist that halts rapidly proliferating trophoblastic cells. Indicated for hemodynamically stable patients with unruptured ectopic mass $< 3.5\text{ cm}$, absence of fetal cardiac activity, serum $\beta\text{-hCG} < 5{,}000\text{ mIU/mL}$, and normal liver/renal profiles. Administered as a single IM dose of $50\text{ mg/m}^2$.
• Surgical Management: Indicated for ruptured ectopic, hemodynamic instability, or methotrexate contraindications. Consists of laparoscopic or open salpingectomy (complete excision of the damaged tube) or salpingostomy (linear antimesenteric tubal incision and extraction of products to conserve tubal architecture for future fertility).
• Rh Prophylaxis: All Rh-negative unsensitized mothers must receive Anti-D Immunoglobulin (RhoGAM) to prevent Rh isoimmunization.

---

5. Hyperemesis Gravidarum

Hyperemesis gravidarum represents severe, intractable nausea and vomiting during the first half of pregnancy resulting in maternal dehydration, weight loss exceeding $> 5\%$ of pre-pregnancy weight, ketonuria, and electrolyte disturbances.

• Pathogenesis: Associated with rapidly rising concentrations of hCG and estrogen; occurs with higher frequency in multiple gestations and gestational trophoblastic disease (hydatidiform mole).
• Metabolic Derangements: Protracted loss of gastric hydrochloric acid and potassium leads to hypokalemic, hypochloremic metabolic alkalosis. Severe starvation leads to ketoacidosis and prerenal azotemia.
• Wernicke's Encephalopathy Risk: Prolonged vomiting depletes maternal thiamine (Vitamin B1) reserves. Administering intravenous glucose infusions without prior thiamine administration can precipitate acute Wernicke's encephalopathy, characterized by the clinical triad of ataxia, global confusion, and ophthalmoplegia/nystagmus. Mandatory Rule: Always administer intravenous thiamine (100 mg) prior to or alongside IV dextrose fluids.
• Clinical Nursing Care: Maintain strict NPO initially; infuse balanced IV crystalloids (Ringer's lactate or normal saline with potassium chloride supplementation); administer prescribed antiemetics (doxylamine-pyridoxine, ondansetron, promethazine, metoclopramide); monitor daily weights, fluid balance charts, and urine ketone levels; gradually reintroduce small, dry, high-protein meals.